23 results
Thumbnail

D1.472 - Features of the intestinal microbiota composition in infants with allergy: comparison of two diagnostic methods

Thumbnail

D1.473 - Features of the intestinal microbiota composition in infants with IgE- and non-IgE-mediated allergy

Thumbnail

D1.476 - Impact of neonatal vaccination on the incidence of atopic dermatitis in children by 36 months: a prospective cohort study

Thumbnail

D1.480 - Polysomnographic phenotypes of sleep-disordered breathing in children with asthma: a systematic review

Thumbnail

D1.467 - Economic Burden of Allergic Diseases in Children: Global Evidence and Implications for Kyrgyzstan

Thumbnail

D1.475 - Significance of air-trapping and pulmonary hyperinflation in the severity of broncho-obstructive manifestations in children with cystic fibrosis

Thumbnail

D1.478 - Hyper-IgE in allergic bronchopulmonary aspergillosis: diagnostic challenges

Thumbnail

D1.479 - Lung function in children with cystic fibrosis associated with wheezing

Thumbnail

D2.507 - School dust Streptomyces and Mycobacterium exposure and respiratory health in European children: the SINPHONIE study

Thumbnail

D2.508 - Climate Change, Allergic Diseases, and Mental Health in Outdoor Workers: A Transdisciplinary Perspective from CliMent COST Action

Thumbnail

D2.509 - Do macrophages modulate the response of injured bronchial epithelium after PM2.5 and microplastic exposure?

Thumbnail

D2.511 - Beyond PFAS: Atypical oral manifestation of eosinophilic esophagitis in a patient with birch allergy. Case Description

Thumbnail

D2.514 - Breathing zone pollen and fungal spore monitoring with an IOM Personal Sampler: A pilot study

Thumbnail

D2.515 - Symptom forecasting for birch and grass pollen allergy: the #berlinbreathing project

Thumbnail

D2.517 - #berlinbreathing : An app-based citizen science project for pollen allergies

Thumbnail

D3.419 - Efficacy, safety, and remission outcomes of omalizumab in elderly patients with severe allergic asthma: a subgroup analysis by age of onset

Thumbnail

D3.420 - Real-world epidemiologic characteristics of patients treated with dupilumab for type 2 inflammatory indications: a single-center retrospective cohort study

Thumbnail

D3.422 - Dupilumab in children with multimorbid atopic phenotype: therapy efficacy, safety and biomarker changes

Thumbnail

D3.424 - Retrospective Analysis of Self-Administration of Biologic Treatments for Severe Asthma and Chronic Urticaria

Thumbnail

D3.426 - Predicting response to omalizumab in patients with chronic spontaneous urticaria: The first results of the global multicenter UCARE SCOPUS project